These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 30206210)

  • 1. A live attenuated vaccine prevents replication and transmission of H7N9 highly pathogenic influenza viruses in mammals.
    Yang W; Yin X; Guan L; Li M; Ma S; Shi J; Deng G; Suzuki Y; Chen H
    Emerg Microbes Infect; 2018 Sep; 7(1):153. PubMed ID: 30206210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino Acid Mutations A286V and T437M in the Nucleoprotein Attenuate H7N9 Viruses in Mice.
    Ma S; Zhang B; Shi J; Yin X; Wang G; Cui P; Liu L; Deng G; Jiang Y; Li C; Chen H
    J Virol; 2020 Jan; 94(2):. PubMed ID: 31666373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Single Amino Acid Substitution at Residue 218 of Hemagglutinin Improves the Growth of Influenza A(H7N9) Candidate Vaccine Viruses.
    Li X; Gao Y; Ye Z
    J Virol; 2019 Oct; 93(19):. PubMed ID: 31270231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A live attenuated vaccine prevents replication and transmission of H7N9 virus in mammals.
    Kong H; Zhang Q; Gu C; Shi J; Deng G; Ma S; Liu J; Chen P; Guan Y; Jiang Y; Chen H
    Sci Rep; 2015 Jun; 5():11233. PubMed ID: 26058711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. H7N9 Live Attenuated Influenza Vaccine Is Highly Immunogenic, Prevents Virus Replication, and Protects Against Severe Bronchopneumonia in Ferrets.
    de Jonge J; Isakova-Sivak I; van Dijken H; Spijkers S; Mouthaan J; de Jong R; Smolonogina T; Roholl P; Rudenko L
    Mol Ther; 2016 May; 24(5):991-1002. PubMed ID: 26796670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a high-yield live attenuated H7N9 influenza virus vaccine that provides protection against homologous and heterologous H7 wild-type viruses in ferrets.
    Chen Z; Baz M; Lu J; Paskel M; Santos C; Subbarao K; Jin H; Matsuoka Y
    J Virol; 2014 Jun; 88(12):7016-23. PubMed ID: 24719414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of Whole, Inactivated, Low Pathogenicity Influenza A(H7N9) Vaccine against Antigenically Distinct, Highly Pathogenic H7N9 Virus.
    Hatta M; Zhong G; Chiba S; Lopes TJS; Neumann G; Kawaoka Y
    Emerg Infect Dis; 2018 Oct; 24(10):1910-1913. PubMed ID: 30226171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation and Characterization of Live Attenuated Influenza A(H7N9) Candidate Vaccine Virus Based on Russian Donor of Attenuation.
    Shcherbik S; Pearce N; Balish A; Jones J; Thor S; Davis CT; Pearce M; Tumpey T; Cureton D; Chen LM; Villanueva J; Bousse TL
    PLoS One; 2015; 10(9):e0138951. PubMed ID: 26405798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative studies of infectivity, immunogenicity and cross-protective efficacy of live attenuated influenza vaccines containing nucleoprotein from cold-adapted or wild-type influenza virus in a mouse model.
    Isakova-Sivak I; Korenkov D; Smolonogina T; Tretiak T; Donina S; Rekstin A; Naykhin A; Shcherbik S; Pearce N; Chen LM; Bousse T; Rudenko L
    Virology; 2017 Jan; 500():209-217. PubMed ID: 27829176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of mice and ferrets to a monovalent influenza A (H7N9) split vaccine.
    Duan Y; Gu H; Chen R; Zhao Z; Zhang L; Xing L; Lai C; Zhang P; Li Z; Zhang K; Wang Z; Zhang S; Wang X; Yang P
    PLoS One; 2014; 9(6):e99322. PubMed ID: 24937303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A live attenuated H7N7 candidate vaccine virus induces neutralizing antibody that confers protection from challenge in mice, ferrets, and monkeys.
    Min JY; Vogel L; Matsuoka Y; Lu B; Swayne D; Jin H; Kemble G; Subbarao K
    J Virol; 2010 Nov; 84(22):11950-60. PubMed ID: 20810733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid Evolution of H7N9 Highly Pathogenic Viruses that Emerged in China in 2017.
    Shi J; Deng G; Ma S; Zeng X; Yin X; Li M; Zhang B; Cui P; Chen Y; Yang H; Wan X; Liu L; Chen P; Jiang Y; Guan Y; Liu J; Gu W; Han S; Song Y; Liang L; Qu Z; Hou Y; Wang X; Bao H; Tian G; Li Y; Jiang L; Li C; Chen H
    Cell Host Microbe; 2018 Oct; 24(4):558-568.e7. PubMed ID: 30269969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plant-derived H7 VLP vaccine elicits protective immune response against H7N9 influenza virus in mice and ferrets.
    Pillet S; Racine T; Nfon C; Di Lenardo TZ; Babiuk S; Ward BJ; Kobinger GP; Landry N
    Vaccine; 2015 Nov; 33(46):6282-9. PubMed ID: 26432915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence and Adaptation of a Novel Highly Pathogenic H7N9 Influenza Virus in Birds and Humans from a 2013 Human-Infecting Low-Pathogenic Ancestor.
    Qi W; Jia W; Liu D; Li J; Bi Y; Xie S; Li B; Hu T; Du Y; Xing L; Zhang J; Zhang F; Wei X; Eden JS; Li H; Tian H; Li W; Su G; Lao G; Xu C; Xu B; Liu W; Zhang G; Ren T; Holmes EC; Cui J; Shi W; Gao GF; Liao M
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29070694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Assessment of Fifth-Wave H7N9 Influenza A Viruses in Mammalian Models.
    Sun X; Belser JA; Pappas C; Pulit-Penaloza JA; Brock N; Zeng H; Creager HM; Le S; Wilson M; Lewis A; Stark TJ; Shieh WJ; Barnes J; Tumpey TM; Maines TR
    J Virol; 2019 Jan; 93(1):. PubMed ID: 30305359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant baculovirus vaccine expressing hemagglutinin of H7N9 avian influenza virus confers full protection against lethal highly pathogenic H7N9 virus infection in chickens.
    Hu J; Liang Y; Hu Z; Wang X; Gu M; Li R; Ma C; Liu X; Hu S; Chen S; Peng D; Jiao X; Liu X
    Arch Virol; 2019 Mar; 164(3):807-817. PubMed ID: 30671655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H7N9 virulent mutants detected in chickens in China pose an increased threat to humans.
    Shi J; Deng G; Kong H; Gu C; Ma S; Yin X; Zeng X; Cui P; Chen Y; Yang H; Wan X; Wang X; Liu L; Chen P; Jiang Y; Liu J; Guan Y; Suzuki Y; Li M; Qu Z; Guan L; Zang J; Gu W; Han S; Song Y; Hu Y; Wang Z; Gu L; Yang W; Liang L; Bao H; Tian G; Li Y; Qiao C; Jiang L; Li C; Bu Z; Chen H
    Cell Res; 2017 Dec; 27(12):1409-1421. PubMed ID: 29151586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Key Amino Acids in the PB2 and M1 Proteins of H7N9 Influenza Virus That Affect Its Transmission in Guinea Pigs.
    Kong H; Ma S; Wang J; Gu C; Wang Z; Shi J; Deng G; Guan Y; Chen H
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31597771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a parainfluenza virus 5 (PIV5)-based H7N9 vaccine in mice and guinea pigs: antibody titer towards HA was not a good indicator for protection.
    Li Z; Gabbard JD; Johnson S; Dlugolenski D; Phan S; Tompkins SM; He B
    PLoS One; 2015; 10(3):e0120355. PubMed ID: 25803697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-protection against H7N9 influenza strains using a live-attenuated H7N3 virus vaccine.
    Carter DM; Bloom CE; Kirchenbaum GA; Tsvetnitsky V; Isakova-Sivak I; Rudenko L; Ross TM
    Vaccine; 2015 Jan; 33(1):108-16. PubMed ID: 25448100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.